期刊
CARDIOVASCULAR RESEARCH
卷 74, 期 2, 页码 290-303出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.cardiores.2007.02.007
关键词
developmental biology; contractile function; heart failure; cardiomyopathy
资金
- NHLBI NIH HHS [R01 HL073348] Funding Source: Medline
Objective: Cardiac contractility is regulated tightly as an extrinsic and intrinsic homeostatic mechanism to the heart. The molecular basis of the intrinsic system is largely unknown. Here, we test the hypothesis that bone morphogenetic protein-2 (BMP-2) mediates embryonic cardiac contractility upstream of myocyte-specific enhancer factor 2A (MEF2A). Methods: The BMP-2 and MEF2A expression pattern was analyzed by RT-PCR, Western blotting, whole-mount in situ hybridization, and an in vivo transgenic approach. The cardiac phenotype of BMP-2 and MEF2A knock-down zebrafish embryos was analysed. Cardiac contractions were recorded with a video camera. Myofibrillar organization was observed with transmission electron microscopy. Gene expression profiles were performed by quantitative real-time PCR analysis. Results: We demonstrate that BMP-2 and MEF2A are co-expressed in embryonic and neonatal cardiac myocytes. Furthermore, we provide evidence that BMP-2 is required for cardiac contractility in vitro and in vivo and that MEF2A expression can be activated by BMP-2 signaling in neonatal cardiomyocytes. BMP-2 is involved in the assembly of the cardiac contractile apparatus. Finally, we find that exogenous MEF2A is sufficient to rescue ventricular contractility defects in the absence of BMP-2 function. Conclusions: In all, these observations indicate that BMP-2 and MEF2A are key components of a pathway that controls the cardiac vetricular contractility and suggest that the BMP2-MEF2A pathway can offer new opportunities for the treatment of heart failure. (c) 2007 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据